These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7114595)
21. Inhibition of monoamine oxidase activity by phenylpropanolamine, an anorectic agent. Yu PH Res Commun Chem Pathol Pharmacol; 1986 Feb; 51(2):163-71. PubMed ID: 3961266 [TBL] [Abstract][Full Text] [Related]
22. Phenylpropanolamine and blood pressure: a review of prospective studies. Morgan JP; Funderburk FR Am J Clin Nutr; 1992 Jan; 55(1 Suppl):206S-210S. PubMed ID: 1728835 [TBL] [Abstract][Full Text] [Related]
23. Hypertensive crisis secondary to phenylpropanolamine interacting with triple-drug therapy for HIV prophylaxis. Khurana V; de la Fuente M; Bradley TP Am J Med; 1999 Jan; 106(1):118-9. PubMed ID: 10320127 [No Abstract] [Full Text] [Related]
24. Phenylpropanolamine and stroke: the study, the FDA ruling, the implications. Mersfelder TL Cleve Clin J Med; 2001 Mar; 68(3):208-9, 213-9, 223. PubMed ID: 11263849 [TBL] [Abstract][Full Text] [Related]
25. Severe hypertension produced by interaction of phenylpropanolamine with methyldopa and oxprenolol. McLaren EH Br Med J; 1976 Jul; 2(6030):283-4. PubMed ID: 953565 [No Abstract] [Full Text] [Related]
27. Treatment of MAOI hypertensive crisis with sublingual nifedipine. Clary C; Schweizer E J Clin Psychiatry; 1987 Jun; 48(6):249-50. PubMed ID: 3584082 [TBL] [Abstract][Full Text] [Related]
28. Phenylpropanolamine and associated myocardial injury. Leo PJ; Hollander JE; Shih RD; Marcus SM Ann Emerg Med; 1996 Sep; 28(3):359-62. PubMed ID: 8780486 [TBL] [Abstract][Full Text] [Related]
29. Phenylpropanolamine and other over-the-counter vasoactive compounds. Bravo EL Hypertension; 1988 Mar; 11(3 Pt 2):II7-10. PubMed ID: 3280497 [TBL] [Abstract][Full Text] [Related]
30. Hypertension due to anorectic agent. Shapiro SR N Engl J Med; 1969 Jun; 280(24):1363. PubMed ID: 5783669 [No Abstract] [Full Text] [Related]
31. Evaluation of the potential for pharmacodynamic and pharmacokinetic drug interactions between selegiline transdermal system and two sympathomimetic agents (pseudoephedrine and phenylpropanolamine) in healthy volunteers. Azzaro AJ; VanDenBerg CM; Ziemniak J; Kemper EM; Blob LF; Campbell BJ J Clin Pharmacol; 2007 Aug; 47(8):978-90. PubMed ID: 17554106 [TBL] [Abstract][Full Text] [Related]
32. Neurologic signs and symptoms related to over-the-counter diet pills. Mueller SM; Graham JD; Duggan D Indiana Med; 1985 May; 78(5):388-90. PubMed ID: 3998456 [No Abstract] [Full Text] [Related]
34. Phenylpropanolamine-associated CNS complications in children and adolescents. Bale JF; Fountain MT; Shaddy R Am J Dis Child; 1984 Jul; 138(7):683-5. PubMed ID: 6428218 [TBL] [Abstract][Full Text] [Related]
35. Acute memory loss and nominal aphasia caused by phenylpropanolamine. Puar HS South Med J; 1984 Dec; 77(12):1604-5. PubMed ID: 6505775 [TBL] [Abstract][Full Text] [Related]
36. Case report: Dexatrim (Phenylpropanolamine) as a cause of myocardial infarction. Pilsczek FH; Karcic AA; Freeman I Heart Lung; 2003; 32(2):100-4. PubMed ID: 12734532 [TBL] [Abstract][Full Text] [Related]